Evidence map›Paper›PMID 26468154›Full record

ReviewCurrent diabetes reports2015

Epidemiology of NAFLD and Type 2 Diabetes: Health Disparities Among Persons of Hispanic Origin.

Mariana Lazo, Usama Bilal, Rafael Perez-Escamilla

2 registry-linked trialsAbstract readReview
PubMed Publisher
In one paragraph

Review in Current diabetes reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04007419 nacompletednot on this mapstarted 2016, after this paper: background citation

Promotoras de Donación: Leveraging Community Health Workers to Increase Donor Registration of Older Hispanics

TypeinterventionalSponsorTemple UniversityRan2016 to 2020Enrolled621ConditionsOrgan Donation, Donor Designation/RegistrationArmsHealth Promoters and Organ Donation
NCT04186260 nacompletednot on this mapstarted 2024, after this paper: background citation

A Gender and Culturally Specific Approach to Reduce NAFLD in Mexican-American Men

TypeinterventionalSponsorUniversity of ArizonaRan2024 to 2025Enrolled15ConditionsNAFLDArmsNAFLD-specific weight loss intervention, Wait-list control
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. How Mexicans' Emotional Responses to Non-Alcoholic Fatty Liver Disease Can Help Inform Culturally Congruent Health Care.Journal of transcultural nursing : official journal of the Transcultural Nursing Society · 2022
    Article
  11. Article
  12. Prediction of Pancreatic Cancer in Diabetes Patients with Worsening Glycemic Control.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. The association between etiology of hepatocellular carcinoma and race-ethnicity in Florida.Liver international : official journal of the International Association for the Study of the Liver · 2020
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Mariana LazoDivision of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. mlazo@jhu.edu.
Usama BilalThe Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, 2024 E. Monument Street 2-615, Baltimore, MD, 21205, USA. ubilal@jhmi.edu.
Rafael Perez-EscamillaDepartment of Chronic Disease Epidemiology, Yale School of Public Health, 135 College St. (Suite 200), New Haven, CT, 06510, USA. rafael.perez-escamilla@yale.edu.
Johns Hopkins Medicine · USJohns Hopkins University · USYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver condition in the USA and worldwide and affects Hispanics disproportionally. In this review, we aim to document and contrast the epidemiology of NAFLD and type 2 diabetes, provide a framework to study health disparities in NAFLD in Hispanic populations, and identify points of action within the health care system to tackle these health disparities. NAFLD shares many common risk factors with type 2 diabetes, specially obesity and insulin resistance, but shows different prevalence patterns by ethnicity: while Hispanics are disproportionately affected by both NAFLD and type 2 diabetes, non-Hispanic black populations have a low prevalence of NAFLD. The current literature suggests a strong role of polymorphisms in the PNPLA3 gene and potential interactions with environmental factors in the pathogenesis of NAFLD. However, given potential interactions and the shared risk factors with type 2 diabetes, a health disparity approach that acknowledges upstream determinants is needed. Solutions to these determinants can also be found in the health system. The role of interventions that have shown efficacy in type 2 diabetes, like community health workers, may be implemented to prevent and control NAFLD.

Indexed as

AnimalsDiabetes Mellitus, Type 2Hispanic or LatinoHumansInsulin ResistanceNon-alcoholic Fatty Liver DiseaseObesityPrevalenceRisk FactorsEpidemiologyHealth disparitiesHispanicsNon-alcoholic fatty liver diseasePNPLA3Type 2 diabetes

Identifiers

PMID26468154
OpenAlexW1921835937

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.